Cart
sales@molnova.com
Fructo-oligosaccharide DP10/GF9
CAS No. 118150-64-4
Fructo-oligosaccharide DP10/GF9( ——— )
Catalog No. M38924 CAS No. 118150-64-4
Fructo-oligosaccharide DP10/GF9 belongs to fructooligosaccharides (FOS) with degree of polymerization (DP=10). Fructo-oligosaccharides (FOS) are composed of 9 fructose units linked by (2→1)-β-glycosidic bonds and having a single D-glucosyl unit at the non-reducing end.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 244 | In Stock |
|
| 10MG | 361 | In Stock |
|
| 25MG | 606 | In Stock |
|
| 50MG | 828 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFructo-oligosaccharide DP10/GF9
-
NoteResearch use only, not for human use.
-
Brief DescriptionFructo-oligosaccharide DP10/GF9 belongs to fructooligosaccharides (FOS) with degree of polymerization (DP=10). Fructo-oligosaccharides (FOS) are composed of 9 fructose units linked by (2→1)-β-glycosidic bonds and having a single D-glucosyl unit at the non-reducing end.
-
DescriptionFructo-oligosaccharide DP10/GF9 belongs to fructooligosaccharides (FOS) with degree of polymerization (DP=10).
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number118150-64-4
-
Formula Weight1639.42
-
Molecular FormulaC60H102O51
-
Purity>98% (HPLC)
-
SolubilityH2O : 125 mg/mL (76.25 mM; ultraphonic)
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Martins GN, et al. Technological Aspects of the Production of Fructo and Galacto-Oligosaccharides. EnzymaticSynthesis and Hydrolysis. Front Nutr. 2019 May 31;6:78.?
molnova catalog
related products
-
ML337
negative allosteric modulator of mGlu3.
-
BV02
BV02 is an inhibitor of 14-3-3 protein-protein interactions and can be used in studies about the treatment of chronic myeloid leukemia. BV02 disrupts hematopoietic cells expressing the IM-resistant T315I mutation and the IM-sensitive wild-type Bcr-Abl.
-
2,3-Dihydroxy-4-meth...
2,3-Dihydroxy-4-methoxybenzoic acid is a compound isolated from [sweet cherry fruit].
